🔴 Conexeu Sciences is trading 11% down today with no clear company-specific catalyst

Conexeu Sciences is trading at $3.36, down 10.87%, as of 11:51 a.m. ET on October 13, 2026, with no clear company-specific catalyst identified.

• No October 13 company announcement was listed; the latest update, on October 6, concerned work toward a planned FDA 510(k) submission.
• Biotech ETF XBI was down 2.01% during the session, providing sector context but not establishing the cause of Conexeu Sciences’ larger decline.